{
  "ticker": "EXAS",
  "company_name": "Exact Sciences Corporation",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06589310",
      "title": "Falcon Real World Evidence Registry",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Cancer",
      "start_date": "2024-08-01",
      "completion_date": "2031-01",
      "enrollment": 0,
      "sponsor": "Exact Sciences Corporation"
    },
    {
      "nct_id": "NCT01397747",
      "title": "Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer",
      "start_date": "2011-06",
      "completion_date": "2013-05",
      "enrollment": 0,
      "sponsor": "Exact Sciences Corporation"
    },
    {
      "nct_id": "NCT05410977",
      "title": "Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Colorectal Carcinoma, Lynch Syndrome",
      "start_date": "2022-03-30",
      "completion_date": "2027-04-01",
      "enrollment": 0,
      "sponsor": "Mayo Clinic"
    },
    {
      "nct_id": "NCT04124406",
      "title": "Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "",
      "condition": "Colon Cancer",
      "start_date": "2019-10-18",
      "completion_date": "2025-12",
      "enrollment": 0,
      "sponsor": "Exact Sciences Corporation"
    },
    {
      "nct_id": "NCT06398743",
      "title": "First CORRECT Study of Minimal Residual Disease (MRD) Detection in Colorectal Cancer",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "",
      "condition": "Colorectal Cancer",
      "start_date": "2023-06-20",
      "completion_date": "2027-12",
      "enrollment": 0,
      "sponsor": "Exact Sciences Corporation"
    },
    {
      "nct_id": "NCT04473625",
      "title": "Stool Collection Sub-Study of Exact Sciences Protocol 2018-01",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Colorectal Cancer, Colo-rectal Cancer, Cancer",
      "start_date": "2020-07-21",
      "completion_date": "2022-05-25",
      "enrollment": 0,
      "sponsor": "Exact Sciences Corporation"
    },
    {
      "nct_id": "NCT06401421",
      "title": "EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Breast Cancer",
      "start_date": "2024-06-07",
      "completion_date": "2030-04",
      "enrollment": 0,
      "sponsor": "Exact Sciences Corporation"
    },
    {
      "nct_id": "NCT03727087",
      "title": "Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma",
      "status": "TERMINATED",
      "phase": "",
      "condition": "Melanoma",
      "start_date": "2019-01-10",
      "completion_date": "2020-03-24",
      "enrollment": 0,
      "sponsor": "Exact Sciences Corporation"
    },
    {
      "nct_id": "NCT03741166",
      "title": "Blood Collection Sub-Study for CRC Screening in Individuals 45-49 at Average Risk for CRC.",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Colo-rectal Cancer",
      "start_date": "2018-11-08",
      "completion_date": "2019-04-05",
      "enrollment": 0,
      "sponsor": "Exact Sciences Corporation"
    },
    {
      "nct_id": "NCT02419716",
      "title": "A Study of Cologuard\u2122 in an Average Risk Population Assessing a Three Year Test Interval",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Colorectal Cancer Screening, Colorectal Cancer",
      "start_date": "2015-04",
      "completion_date": "2020-03-16",
      "enrollment": 0,
      "sponsor": "Exact Sciences Corporation"
    }
  ],
  "summary": {
    "total_trials": 36,
    "by_phase": {
      "": 33,
      "NA": 3
    },
    "by_status": {
      "RECRUITING": 6,
      "COMPLETED": 21,
      "ACTIVE_NOT_RECRUITING": 4,
      "TERMINATED": 5
    },
    "active_trials": 10,
    "completed_trials": 21,
    "conditions": [
      "Barrett Esophagus",
      "Breast Cancer",
      "Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Bladder Cancer, Uterine Cancer, Kidney Cancer, Renal Pelvis Cancer, Pancreatic Cancer, Liver Cancer, Stomach Cancer, Ovarian Cancer, Esophageal Cancer",
      "COVID-19",
      "Cancer",
      "Colo-rectal Cancer",
      "Colon Cancer",
      "Colorectal Cancer",
      "Colorectal Cancer Screening, Colorectal Cancer",
      "Colorectal Cancer, Colo-rectal Cancer, Cancer",
      "Colorectal Carcinoma, Lynch Syndrome",
      "Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer",
      "Early Cancer Detection",
      "Gastro Esophageal Reflux Disease, Barrett Esophagus",
      "Healthy",
      "Hematologic Malignancy",
      "Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer",
      "Hepatocellular Carcinoma, Hepatocellular Carcinoma Surveillance",
      "Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms, Colorectal Cancer",
      "Inflammatory Bowel Disease, Colorectal Neoplasms, Digestive System Diseases, Colonic Diseases, Colorectal Cancer",
      "Lung Cancer (Diagnosis)",
      "Melanoma",
      "Prostate Cancer"
    ],
    "lead_stage": "preclinical"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:36:05.945732",
    "search_query": "Exact Sciences Corporation",
    "url": "https://clinicaltrials.gov/search?term=Exact+Sciences+Corporation"
  }
}